Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activity

被引：0
作者：
Roberta Torcasio
Maria Eugenia Gallo Cantafio
Claudia Veneziano
Carmela De Marco
Ludovica Ganino
Ilenia Valentino
Maria Antonietta Occhiuzzi
Ida Daniela Perrotta
Teresa Mancuso
Filomena Conforti
Bruno Rizzuti
Enrica Antonia Martino
Massimo Gentile
Antonino Neri
Giuseppe Viglietto
Fedora Grande
Nicola Amodio
机构：
[1] University Magna Graecia of Catanzaro,Department of Experimental and Clinical Medicine
[2] University of Calabria,Department of Biology, Ecology and Earth Sciences
[3] University of Calabria,Department of Pharmacy, Health and Nutritional Sciences
[4] University of Calabria,Department of Biology, Ecology and Earth Sciences, Centre for Microscopy and Microanalysis
[5] Annunziata” Regional Hospital Cosenza,SS Rende (CS), Department of Physics
[6] CNR-NANOTEC,Institute for Biocomputation and Physics of Complex Systems (BIFI), Joint Unit GBsC
[7] University of Calabria,CSIC
[8] University of Zaragoza,BIFI
[9] IRCCS Di Reggio Emilia,Scientific Directorate
来源：
Journal of Translational Medicine | / 22卷
关键词：
Flavanones; Hesperitin; Naringenin; Mitochondrial dynamics; Multiple myeloma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] The IAP antagonist birinapant potentiates bortezomib anti-myeloma activity in vitro and in vivo
    Liang Zhou
    Yu Zhang
    Yun Leng
    Yun Dai
    Maciej Kmieciak
    Lora Kramer
    Kanika Sharma
    Yan Wang
    William Craun
    Steven Grant
    Journal of Hematology & Oncology, 12
  • [22] SHP2 Inhibitors Show Anti-Myeloma Activity and Synergize With Bortezomib in the Treatment of Multiple Myeloma
    Zhou, Pan
    Xiao, Mengyu
    Li, Weiya
    Sun, Xiaobai
    Bai, Yanliang
    Meng, Feiying
    Zhu, Zunmin
    Yuan, Weiping
    Sun, Kai
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [23] Cannabinoid derivatives exert a potent anti-myeloma activity both in vitro and in vivo
    Victoria Barbado, M.
    Medrano, Mayte
    Caballero-Velazquez, Teresa
    Alvarez-Laderas, Isabel
    Ignacio Sanchez-Abarca, Luis
    Garcia-Guerrero, Estefania
    Martin-Sanchez, Jesus
    Valle Rosado, Ivan
    Ignacio Piruat, Jose
    Gonzalez-Naranjo, Pedro
    Eugenia Campillo, Nuria
    Antonio Paez, Juan
    Antonio Perez-Simon, Jose
    INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (03) : 674 - 685
  • [24] Anti-myeloma effect of homoharringtonine with concomitant targeting of the myeloma-promoting molecules, Mcl-1, XIAP, and β-catenin
    Junya Kuroda
    Yuri Kamitsuji
    Shinya Kimura
    Eishi Ashihara
    Eri Kawata
    Yoko Nakagawa
    Miki Takeuichi
    Yoshihide Murotani
    Asumi Yokota
    Ruriko Tanaka
    Michael Andreeff
    Masafumi Taniwaki
    Taira Maekawa
    International Journal of Hematology, 2008, 87 : 507 - 515
  • [25] Anti-myeloma effect of homoharringtonine with concomitant targeting of the myeloma-promoting molecules, Mcl-1, XIAP, and β-catenin
    Kuroda, Junya
    Kamitsuji, Yuri
    Kimura, Shinya
    Ashihara, Eishi
    Kawata, Eri
    Nakagawa, Yoko
    Takeuichi, Miki
    Murotani, Yoshihide
    Yokota, Asumi
    Tanaka, Ruriko
    Andreeff, Michael
    Taniwaki, Masafumi
    Maekawa, Taira
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 87 (05) : 507 - 515
  • [26] Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways
    T Kobayashi
    J Kuroda
    E Ashihara
    S Oomizu
    Y Terui
    A Taniyama
    S Adachi
    T Takagi
    M Yamamoto
    N Sasaki
    S Horiike
    K Hatake
    A Yamauchi
    M Hirashima
    M Taniwaki
    Leukemia, 2010, 24 : 843 - 850
  • [27] Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways
    Kobayashi, T.
    Kuroda, J.
    Ashihara, E.
    Oomizu, S.
    Terui, Y.
    Taniyama, A.
    Adachi, S.
    Takagi, T.
    Yamamoto, M.
    Sasaki, N.
    Horiike, S.
    Hatake, K.
    Yamauchi, A.
    Hirashima, M.
    Taniwaki, M.
    LEUKEMIA, 2010, 24 (04) : 843 - 850
  • [28] The generation and anti-myeloma activity of a chimeric anti-CD54 antibody, cUV3
    Smallshaw, JE
    Coleman, E
    Spiridon, C
    Vitetta, ES
    JOURNAL OF IMMUNOTHERAPY, 2004, 27 (06) : 419 - 424
  • [29] The proteasome inhibitor CEP-18770 enhances the anti-myeloma activity of bortezomib and melphalan
    Sanchez, Eric
    Li, Mingjie
    Steinberg, Jeffrey A.
    Wang, Cathy
    Shen, Jing
    Bonavida, Benjamin
    Li, Zhi-Wei
    Chen, Haiming
    Berenson, James R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 148 (04) : 569 - 581
  • [30] Preclinical anti-myeloma activity of the novel HDAC-inhibitor JNJ-26481585
    Stuehmer, Thorsten
    Arts, Janine
    Chatterjee, Manik
    Borawski, Johanna
    Wolff, Andre
    King, Peter
    Einsele, Hermann
    Leo, Eugen
    Bargou, Ralf C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 (04) : 529 - 536
12345